Pharmacy Innovations recalls THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL 25MG/25MG/25MG/25MG/25MG/20MG/ML (3ML VIAL) INJECTABLE THIAMINE
Recalled February 1, 2023 · FDA recall D-0239-2023 · Pharmacy Innovations
Hazard
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. · FDA Class II
Units
N/A
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Product
THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL 25MG/25MG/25MG/25MG/25MG/20MG/ML (3ML VIAL) INJECTABLE THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/METHYLFOLATE/METHYLCOBAL 10MG/2.5MG/25MG/5MG/5MG/10MG/10MG/ML (1ML VIAL) INJECTABLE THIAMINE/RIBOFLAVIN/NIACINAMIDE/DEXPANTHENOL/PYRIDOXINE 50MG/1MG/100MG/3MG/2MG/ML (30ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Manufacturer(s)
Pharmacy Innovations
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →